A 10-Minute Cardiovascular Magnetic Resonance Protocol for Cardiac Disease
NCT ID: NCT04464655
Last Updated: 2024-10-24
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
RECRUITING
2130 participants
OBSERVATIONAL
2019-12-12
2025-01-31
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Cardiac Magnetic Resonance for Diagnosis, Treatment Guidance and Prognosis of Cardiac Masses (CMR)
NCT07335770
Different Methods of Cardiac MRI in Assessment of Estimated Corrected Ejection Fraction in Valvular Heart Diseases
NCT05808465
Magnetic Resonance Imaging of the Blood Vessels of the Heart
NCT00001638
Accelerated Stress CMR in Coronary Artery Disease
NCT05221762
MRI Sequence and Imaging Protocol Development
NCT03040947
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
To test this 10-minute CMR protocol for its ability to significantly improve diagnostic decision-making and to reduce cost.
To test its clinical feasibility, performance and cost-effectiveness in different populations including: Non-ischemic cardiomyopathies (-)OS-CMR and Ischemic Heart Disease and CAD (+)OS-CMR
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
OTHER
PROSPECTIVE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
Healthy Volunteers
Age: \>18 y, No known current or pre-existing medical conditions that would affect the cardiovascular or respiratory system.
No interventions assigned to this group
Patients
Age: \> 18y, Clinically indicated CMR exam
No interventions assigned to this group
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* Age: \>18 y, Informed consent, Clinically indicated CMR exam
Exclusion Criteria
Patients
* General MRI contraindications: MR- incompatible devices such as pacemakers, defibrillators, or implanted material or foreign bodies Vasoactive medication (e.g. nitro) during the 12 hours prior to the exam. Consumption of caffeinated drinks or foods (including cocoa and chocolate) during the 12 hours prior to the exam.
Regular nicotine consumption during the last 6 months
18 Years
ALL
Yes
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
McGill University Health Centre/Research Institute of the McGill University Health Centre
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Matthias Friedrich
Principal Investigator
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Matthias G Friedrich, MD
Role: PRINCIPAL_INVESTIGATOR
Research Institute of the McGill University Health Center
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
McGill University Health Center
Montreal, Quebec, Canada
Countries
Review the countries where the study has at least one active or historical site.
Central Contacts
Reach out to these primary contacts for questions about participation or study logistics.
Facility Contacts
Find local site contact details for specific facilities participating in the trial.
Katerina Eyre, PhD
Role: backup
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
2020-6128
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.